Skip to main content
Clinical Trials/ISRCTN58648476
ISRCTN58648476
Completed
未知

A randomised double-blind controlled trial of BCNU as second-line therapy in metastatic oesophago-gastric, colorectal and pancreatic cancer

The Royal Marsden NHS Foundation Trust (UK)0 sites0 target enrollmentAugust 19, 2002

Overview

Phase
未知
Intervention
Not specified
Conditions
Colon, oesophagus, pancreas, rectum, stomach cancers
Sponsor
The Royal Marsden NHS Foundation Trust (UK)
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 19, 2002
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional

Investigators

Sponsor
The Royal Marsden NHS Foundation Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • Any patient who has progressed on or has a short disease free interval with folinic acid modulated 5\-Fluorouracil (5FU) protracted infusional 5FU regimens

Exclusion Criteria

  • Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials